Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

More articles from Clinical (Oncology: GU)

  • You have access
    Assessing Response to [177Lu]PSMA Radioligand Therapy using modified PSMA PET Progression Criteria
    Kerstin Michalski, Claudius Klein, Tonio Brueggemann, Philipp T Meyer, Cordula Annette Jilg and Juri Ruf
    Journal of Nuclear Medicine March 31, 2021, jnumed.120.260836; DOI: https://doi.org/10.2967/jnumed.120.260836
  • You have access
    GRPr antagonist 68Ga-SB3 PET/CT-imaging of primary prostate cancer in therapy-naive patients
    Ingrid L Bakker, Alida C Fröberg, Martijn B Busstra, J. Fred Verzijlbergen, Mark Konijnenberg, Geert J. L. H. van Leenders, Ivo G Schoots, Erik de Blois, Wytske M van Weerden, Simone U Dalm, Theodosia Maina-Nock, Berthold Artur Nock and Marion de Jong
    Journal of Nuclear Medicine March 31, 2021, jnumed.120.258814; DOI: https://doi.org/10.2967/jnumed.120.258814
  • You have access
    Tumor detection of 18F-PSMA-1007 in the prostate gland in patients with prostate cancer using prostatectomy specimens as reference method
    Elin Tragardh, Athanasios Simoulis, Anders Bjartell and Jonas Jogi
    Journal of Nuclear Medicine March 31, 2021, jnumed.121.261993; DOI: https://doi.org/10.2967/jnumed.121.261993
  • You have access
    A Phase II, Open-label study to assess safety and management change using 68Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
    Asim Afaq, Heather Payne, Reena Davda, John Hines, Gary J.R. Cook, Marie Meagher, Dimitrios Priftakis, Victoria S. Warbey, Anand Kelkar, Clement Orczyk, Anita Mitra, Sarah Needleman, Michael Ferris, Greg Mullen and Jamshed Bomanji
    Journal of Nuclear Medicine March 19, 2021, jnumed.120.257527; DOI: https://doi.org/10.2967/jnumed.120.257527
  • You have access
    Current and emerging clinical applications of PSMA-PET diagnostic imaging for prostate cancer
    Andrea Farolfi, Letizia Calderoni, Francesco Mattana, Riccardo Mei, Silvi Telo, Stefano Fanti and Paolo Castellucci
    Journal of Nuclear Medicine March 12, 2021, jnumed.120.257238; DOI: https://doi.org/10.2967/jnumed.120.257238
  • You have access
    Combination of forced diuresis with additional late imaging in 68Ga-PSMA-11 PET/CT – effects on lesion visibility and radiotracer uptake
    Ian Alberts, Jan Niklas Huenermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Laeppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
    Journal of Nuclear Medicine March 12, 2021, jnumed.120.257741; DOI: https://doi.org/10.2967/jnumed.120.257741
  • You have access
    Detection efficacy of 18F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment
    Isabel Rauscher, Amir Karimzadeh, Kilian Schiller, Thomas Horn, Calogero D'Alessandria, Charlott Franz, Hannah Wörther, Noemi Nguyen, Stephanie E Combs, Wolfgang Andreas Weber and Matthias Eiber
    Journal of Nuclear Medicine March 12, 2021, jnumed.120.260091; DOI: https://doi.org/10.2967/jnumed.120.260091
  • You have access
    PSMA- and GRPR-targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer
    Lucia Baratto, Hong Song, Heying Duan, Negin Hatami, Hilary Bagshaw, Mark Buyyounouski, Steven Hancock, Sumit Anil Shah, Sandy Srinivas, Patrick Swift, Farshad Moradi, Guido A Davidzon and Andrei Iagaru
    Journal of Nuclear Medicine March 5, 2021, jnumed.120.259630; DOI: https://doi.org/10.2967/jnumed.120.259630
  • You have access
    Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
    Katherine A. Zukotynski, Urban Emmenegger, Sebastien Hotte, Anil Kapoor, Wei Fu, Amanda L. Blackford, John Valliant, Francois Benard, Chun K. Kim, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis, Kenneth J. Pienta, Michael A. Gorin, Matthew Lubanovic, Jihyun Kim, Martin G. Pomper, Steve Y. Cho and Steven P. Rowe
    Journal of Nuclear Medicine February 19, 2021, jnumed.120.259069; DOI: https://doi.org/10.2967/jnumed.120.259069
  • You have access
    Matched-pair comparison of 18F-DCFPyL PET/CT and 18F-PSMA-1007 PET/CT in 240 prostate cancer patients; inter-reader agreement and lesion detection rate of suspected lesions
    Maurits Wondergem, Friso M van der Zant, Wouter AM Broos and Remco JJ Knol
    Journal of Nuclear Medicine February 5, 2021, jnumed.120.258574; DOI: https://doi.org/10.2967/jnumed.120.258574

Pages

  • Next
  • 1
  • 2
  • 3
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire